title: Morphokinetic reaction of cells of Streptococcus faecalis (ATCC 9790) to specific inhibition of macromolecular synthesis: dependence of mesosome growth on deoxyribonucleic acid synthesis.
abstract: The application of quantitative electron microscopy to thin sections of cells of Streptococcus faecalis specifically inhibited for deoxyribonucleic acid (DNA), ribonucleic acid, and protein synthesis shows that septal mesosomes (i) increase in size when protein synthesis is inhibited by at least 80% while DNA synthesis proceeds at no less than 50% of the control rate and (ii) decrease in size when DNA synthesis is inhibited 50% or more during the initial 10 min of treatment. This indicates that fluctuations in mesosome size are dependent on the extent of DNA synthesis. The fluctuations in mesosome areas observed on treatment do not correlate with the kinetics of glycerol incorporation per milliliter of a culture. However, when glycerol incorporation is placed on a per cell basis, a strong correlation is observed between increases in (i) the thickness of the electron-transparent layer of the cytoplasmic membrane and (ii) the amount of glycerol incorporated per cell. It seems that the electron-transparent membrane layer may thicken to accommodate changes in lipid content when protein and lipid synthesis are uncoupled.
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001374:Azacitidine / Q000494:pharmacology; D001426:Bacterial Proteins / Q000096:biosynthesis; D001431:Bacteriological Techniques; D002247:Carbon Isotopes; D002455:Cell Division; D002462:Cell Membrane / Q000378:metabolism*; D002701:Chloramphenicol / Q000494:pharmacology; D003470:Culture Media; D004269:DNA, Bacterial / Q000096:biosynthesis*; D003609:Dactinomycin / Q000494:pharmacology; D013293:Enterococcus faecalis / Q000166:cytology* / Q000378:metabolism; D005990:Glycerol / Q000378:metabolism; D007930:Leucine / Q000378:metabolism; D046911:Macromolecular Substances / Q000096:biosynthesis*; D008854:Microscopy, Electron; D008937:Mitomycins / Q000494:pharmacology; D012329:RNA, Bacterial / Q000096:biosynthesis; D012293:Rifampin / Q000494:pharmacology; D013053:Spectrophotometry; D013912:Threonine / Q000378:metabolism; D013936:Thymidine / Q000378:metabolism; D014316:Tritium; D014498:Uracil / Q000378:metabolism
chemical_list: D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D002247:Carbon Isotopes; D003470:Culture Media; D004269:DNA, Bacterial; D046911:Macromolecular Substances; D008937:Mitomycins; D012329:RNA, Bacterial; D014316:Tritium; D003609:Dactinomycin; D013912:Threonine; D014498:Uracil; D002701:Chloramphenicol; D007930:Leucine; D001374:Azacitidine; D005990:Glycerol; D013936:Thymidine; D012293:Rifampin